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Blood production from hematopoietic stem and progenitor cells (HSPCs) is a tightly regulated process, controlled by cell-intrinsic mechanisms and external signals from the BM 
microenvironment. Highly complex and dynamic niches formed 
by multiple non-hematopoietic cellular entities, such as mesenchy-
mal stromal cells (MSCs), endothelial cells, osteoblasts, adipocytes, 
and sympathetic nerves have an important role in sustaining blood 
development1–3.
HSCs are found mainly in close contact with the BM vascula-
ture and MSCs, which are crucial components of the perivascular 
niche4–8. MSCs comprise a heterogeneous cell population that can be 
identified by the absence of hematopoietic and endothelial mark-
ers, by their ability to adhere and by their capacity to differentiate 
into a variety of cell types, including osteoblasts, adipocytes, chon-
drocytes and myocytes9. Studies using reporter and conditional 
gene-targeted mice identified stromal subsets in the adult BM 
that show physical association with HSCs2–4,7,8,10. Cxcl12-abundant 
reticular (CAR) cells are located predominantly near sinusoids, 
and have the potential to differentiate into adipocytes and osteo-
blasts3,11. Lineage tracing experiments revealed that CAR cells sig-
nificantly overlap with perivascular cells that express the leptin 
receptor (LEPR) (ref. 12). CAR cells are the major source of CXCL12 
and stem cell factor (SCF) in the BM, and they regulate self-renewal 
and differentiation of HSCs6,13,14. Two other types of perivascu-
lar cells, namely CD45–CD31–Lin–PDGFRα+Sca1+ (PαS) cells and 
NG2+ cells (positive for the transmembrane proteoglycan NG2), are 
located primarily around arterioles. PαS cells express niche factors, 
such as angiopoietin 1 and CXCL12, although at far lower levels 
than in CAR cells. When transplanted into lethally irradiated mice, 
PαS cells can give rise to reticular cells, osteoblasts and adipocytes15. 
In a reciprocal manner, NG2+ pericytes have been proposed to form 
a specific niche that keeps HSCs in a quiescent state, as ablation 
of NG2+ cells results in the cycling of HSCs and a decrease in 
their long-term repopulating activity8,16,17. Nevertheless, whether 
distinct vascular niches differentially regulate HSC behavior is still 
under debate, as uniform distribution of HSCs in the BM has also 
been reported4,18.
Despite intensive research on the BM microenvironment, rela-
tively little is known about transcriptional regulators that govern 
MSC biology. Expression of the transcription factor osterix in osteo-
blasts and in CAR cell precursors is essential for bone development 
and homing of HSCs into fetal BM19,20. FOXC1, which is enriched 
in CAR cells, regulates the expression of Cxcl12 and Scf, and medi-
ates the maintenance of the niche that supports HSPCs in the BM21. 
Members of the early B cell factor (EBF) family of transcription fac-
tors are expressed in the BM niche and affect BM homeostasis22–24. 
In particular, EBF1, the founding member of the EBF family and 
key regulator of B cell development25, is also expressed in osteoblas-
tic progenitors and is required for adipocyte differentiation22,26,27. 
However, our understanding of its in vivo relevance and the mecha-
nisms underlying the function of EBF1 in the BM microenviron-
ment is limited.
Results
Cellular heterogeneity of CAR and PαS cells. MSCs are one of the 
major components of the HSC niche that consists of several types of 
cells, including CAR and PαS cells. To understand the cellular com-
position of the BM MSCs we sorted approximately 1,500 PαS and 
1,500 CAR cells from both Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice by 
FACS and conducted single-cell RNA sequencing (scRNA-seq) anal-
ysis (Extended Data Fig. 1a). To determine the heterogeneity within 
sorted stromal cells, we performed clustering with outlier detection 
using the RaceID3 algorithm28,29. First, we focused on the analysis of 
wild-type cells to understand the cellular landscape of the BM niche. 
This analysis revealed that CAR cells consist of eight clusters (1, 2, 
3, 4, 5, 6, 13 and 17), whereas PαS cells are partitioned into seven 
clusters (7, 8, 9, 11, 12, 14 and 18) (Fig. 1a). Consistent with previ-
ous reports6,12–14,21,24, Cxcl12, Foxc1, LepR and Ebf3 were expressed 
in virtually all CAR cells and were expressed at modest levels in 
PαS cells (Fig. 1b and Extended Data Fig. 1c). Most clusters of the 
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Fig. 1 | Ebf1-deficient MSCs show impaired function. a, a t-distributed stochastic neighbor embedding (t-SNE) map shows clusters of cells with similar 
transcriptomes within CaR (CD45–CD31–Lin–PDGFRα+Sca1–) and PαS (CD45–CD31–Lin–PDGFRα+Sca1+) populations, derived by the RaceID3 algorithm. 
Data represent 912 single-sorted wild-type cells from 3 independent experiments (n = 4 mice). b, t-SNE maps highlighting normalized expression of Cxcl12, 
Foxc1, Prrx1, LepR, Cspg4 (encoding NG2) and Ebf family members in sequenced CaR and PαS cells. c, heat maps depict log2-transformed normalized 
expression of marker genes (rows) for CaR and PαS cells, across the clusters in each column. Key genes are indicated on the right and a color code for 
gene expression level is provide in the key. d, t-SNE map displaying clusters with statistically significant enrichment of wild-type cells (3, 8, 17, 21 and 26) 
or Ebf1-deficient cells (1, 4, 5 and 14) within CaR and PαS cell populations, calculated using the Fisher’s exact test. Data represent 1,777 single-sorted  
wild-type and knockout cells from 3 independent experiments (n = 4 mice per genotype). e, Number of cells analyzed in each cluster corresponding to d and 
derived from a Fisher’s exact test. *P < 0.05, **P < 0.01, ***P < 0.001 (exact P values and cell numbers for each cluster are provided in Supplementary  
Table 1). KO, knockout; Norm., normalized; WT, wild type.
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CAR population also showed uniform expression of genes involved 
in cell adhesion and migration (Sparc, Cxcl12, Kitl, Vcam1, Igfbp4, 
Igfbp5 and Ibsp), and genes that are markers of adipocytes (Adipoq, 
LepR, Rarres2 and Cebpb) and osteoblasts (Cola1a2, Runx2 and 
Sparc) (Fig. 1c, Extended Data Fig. 1b and Supplementary Table 1). 
However, this analysis also identified genes that are expressed in 
specific CAR cell clusters (Fig. 1c). Cluster 1 and cluster 6 were 
defined by the expression of chemokines and extracellular matrix 
components (Cxcl9, Cxcl10, Cxcl1, Ccl2, Ctgf and Tnc). Cluster 3 
showed abundant expression of genes related to adipocyte function 
(Adipoq, Lpl, Gpx3 and Apoe), whereas cluster 5 was marked by high 
expression of Cxcl14, which encodes an inhibitor of the Cxcl12–
Cxcr4 signaling axis (Fig. 1c). Cluster 13 showed the most distinct 
molecular signature with reduced expression of all markers men-
tioned above and abundant expression of Mid1, Stxbp4, Adtrp, Grk4 
and Vmn2r53 (Extended Data Fig. 1b and Supplementary Table 1).
All clusters of the PαS cell population expressed genes that are 
involved in cell–cell and cell–ECM contacts (Sparc, Col1a2, Col1a1, 
Col1a2 and Col3a1) but individual clusters also exhibited specific 
patterns of gene expression (Fig. 1c, Extended Data Fig. 1b and 
Supplementary Table 1). Cluster 7 showed an osteogenic signature 
marked by Bglap, Spp1 and Col5a1, whereas cluster 18 exhibited a 
chondrogenic signature with abundant expression of Chad, Comp 
and Omd. Cluster 9 was defined by genes that are involved in cell 
adhesion (Cd248, Cd9, Dpt, Mmp2, Fndc1 and Ackr3) and cell sig-
naling (Igfbp6, Ccl11, S100a10 and Axl). This analysis revealed a 
high degree of MSC diversity and identified specific subpopulations 
that express cytokines and adhesion molecules that are potentially 
required for maintaining the HCSs in their niche.
Ebf1 deficiency alters MSC function in  vitro. The EBF family 
of transcription factors has crucial roles in the hematopoietic 
niche22,24,27. Transcripts of Ebf1 were detected in CAR and PαS 
cell populations, whereas Ebf2 and Ebf3 transcripts were found in 
a subset of PαS cells and in all CAR cells, respectively (Fig. 1b). 
Immunoblot analysis confirmed the expression of EBF1 protein 
in both MSC populations (Extended Data Fig. 1d). Therefore, we 
chose to conditionally inactivate the Ebf1 in CAR and PαS cells. To 
investigate whether an Ebf1 deletion alters the composition and/or 
the gene expression profile of the CAR and PαS cell populations, we 
crossed Ebf1 floxed mice (Ebf1fl/fl) to the perivascular niche-specific 
Prx1Cre driver that efficiently targets PαS, CAR and osteoblastic cells 
but does not target the endothelial or hematopoietic compartments 
in the BM1,30. RaceID3-based clustering of single-sorted CAR and 
PαS cells from Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice identified nine 
clusters that are differentially represented between Ebf1-deficient 
and control stromal cells (Fig. 1d and Extended Data Fig. 1e,f). 
Clusters 3, 8 and 21 of the CAR population, and clusters 17 and 
26 of the PαS population were significantly enriched for the wild-
type cells (P < 0.05, two-tailed Fisher’s test). In contrast, cluster 14 
of the CAR population and clusters 1, 4 and 5 of the PαS population 
were predominantly composed of Ebf1-deficient cells (Fig. 1e and 
Supplementary Table 1). In the Ebf1fl/flPrx1Cre MSCs, we observed 
decreased expression of genes that encode secreted factors (Cxcl9, 
Cxcl10, Ccl2, S100a8, S100a9 and Igfbp3), markers of chondro-
cytes (Comp and Wisp2) and adipocytes (Adipoq and Clu), as well 
as increased expression of factors characteristic of osteoblastic cells 
(Bglap, Myoc and Igf2) (Extended Data Fig. 1g and Supplementary 
Table 1). Comparison of our scRNA-seq data with the recently 
published atlases of the total BM microenvironment31,32 revealed a 
substantial overlap with both data sets (Extended Data Fig. 2a,b). 
Despite the altered cellular composition of the CAR and PαS popu-
lations in Ebf1fl/flPrx1Cre mice, we did not observe significant changes 
in the absolute cell numbers or viability (Fig. 2d,e and Extended 
Data Fig. 2c). However, Ebf1-deficient CAR cells showed a modest 
increase in the frequency of cycling cells (Extended Data Fig. 2c).
Previous analysis of Ebf1-null mice showed an increased number 
of adipocytes and osteoblasts in the BM compared to that of wild-
type mice27,33. Therefore, we performed histomorphometric analysis 
of tibiae, which showed modestly increased bone density and osteo-
blast numbers in the trabecular bone area of Ebf1fl/flPrx1Cre mice 
relative to control mice (Extended Data Fig. 3d and Supplementary 
Table 1). In vitro, CAR and PαS cells from Ebf1fl/flPrx1Cre mice gener-
ated fewer colony-forming units for fibroblasts (c.f.u.-Fs) than their 
control counterparts, and c.f.u.-F colonies from Ebf1-deficient PαS 
cells failed to differentiate toward the three mesenchymal lineages 
(Extended Data Fig. 2e–g).
To evaluate the impact of stromal Ebf1 deletion on the mainte-
nance of HSPCs in vitro, we performed long-term culture-initiating 
cell assays. Co-cultures of wild-type HSC-enriched Lin–Sca-1+c-kit+ 
(LSK) cells with MS-5 stromal cells, in which Ebf1 has been knocked 
down using siRNA, showed a twofold reduction in the numbers of 
cobblestone colonies formed by hematopoietic progenitors, relative 
to co-cultures with control feeder cells (Fig. 2a,b). We further exam-
ined the potential of HSPCs from these co-cultures to form c.f.u. 
colonies in methylcellulose medium. HSPCs from co-cultures with 
EBF1-depleted MS-5 feeder cells generated fewer c.f.u.s than those 
from co-cultures with control MS-5 stromal cells (Fig. 2c). Together, 
these data indicate that EBF1 deficiency alters the cellular composi-
tion and functional activities of MSCs.
Loss of HSPCs and myeloid cells in Ebf1fl/flPrx1Cre mice. Analysis 
of the effect of the niche-specific Ebf1 deletion on the hematopoi-
etic cell populations by flow cytometry indicated that Ebf1fl/flPrx1Cre 
mice have normal BM cellularity but have a reduced number and 
frequency of HSCs relative to control mice (Fig. 2f,g and Extended 
Data Fig. 3a). The decrease in HSC number was not caused by an 
increased mobilization of HSPCs to the periphery as the c.f.u. assays 
from the spleen and peripheral blood showed comparable numbers 
of colonies between the groups (Extended Data Fig. 3b). However, 
we detected more apoptotic HSCs in the BM of Ebf1fl/flPrx1Cre mice 
than in the controls (Fig. 2h). Cell cycle analysis revealed a lower 
frequency of HSCs from Ebf1fl/flPrx1Cre mice in the G0 phase and 
a higher frequency in the G1 phase, which suggests that the loss of 
EBF1 in the BM niche promotes the exit of HSCs from quiescence 
(Fig. 2i). Ebf1fl/flPrx1Cre mice also had reduced numbers of myeloid-
biased multipotent progenitors (MPP3) (CD135–CD48+CD150–
LSK) and mature myeloid cells in the BM, and a lower frequency 
of myeloid cells in peripheral blood compared to control mice 
(Fig. 2j–l and Extended Data Fig. 3c). In contrast, no significant 
changes were observed in the erythroid and lymphoid compart-
ments, including in lymphoid-biased MPP4 (CD135+CD150–LSK) 
progenitors, common lymphoid progenitors and cells of the B and 
T cell lineages (Extended Data Fig. 3d,e). Collectively, these results 
further confirm the importance of EBF1 in the stem-cell niche to 
maintain the HSC pool and to support myeloid differentiation.
CAR and NG2+ cells require Ebf1 for their function. To explore the 
role of EBF1 in a more defined subpopulation of MSCs, we crossed 
Ebf1fl/fl mice with LepRCre mice to create an Ebf1 deletion in CAR 
cells located near sinusoids12. Similar to our results in Ebf1fl/flPrx1Cre 
mice, we detected fewer HSCs in the Ebf1fl/flLepRCre mice relative to 
controls, without significant changes in BM cellularity (Fig. 3a and 
Extended Data Fig. 4a). Moreover, the numbers of MPP3 progeni-
tors and mature myeloid cells in the BM, as well as the frequencies of 
myeloid cells in the peripheral blood, were reduced in Ebf1fl/flLepRCre 
mice (Fig. 3b,c and Extended Data Fig. 4b,d). In Ebf1fl/flLepRCre 
mice, we also detected fewer common lymphoid progenitors and 
B cells than in control mice (Extended Data Fig. 4c,f), which may 
be explained by the lower number of CAR cells (Fig. 3d,e), prob-
ably as a result of abundant LepR expression in the entire CAR cell 
population, compared to lower Prx1 expression in the fraction of 
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sequenced CAR cells. No obvious defects were detected in MPP4, 
T  cells or erythroid cells in Ebf1fl/flLepRCre mice (Extended Data 
Fig. 4b,e). Thus, deletion of Ebf1 in CAR cells affects HSPC mainte-
nance and myeloid differentiation.
To examine the impact of Ebf1 deletion in pericytes located near 
arterioles, we crossed Ebf1fl/fl mice with the tamoxifen-inducible 
NG2Cre-ER line, which specifically targets arteriole-associated stro-
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Fig. 2 | Reduced numbers of HSPCs and myeloid cells in mice with a Prx1Cre-mediated deletion of Ebf1 in the BM microenvironment. a, Experimental 
setup and representative immunoblot analysis of EBF1 protein level in total cell extracts of MS-5 cells, 5 weeks after transfection with siRNa targeting 
Ebf1 or a scrambled control (Ctr). actin was used as a loading control, n = 4 independent experiments. b, Number of cobblestone colonies (Ca) after 5 
weeks of co-culture of wild-type LSK cells and MS-5 stromal cells with Ebf1 knockdown. Results are presented as mean ± s.e.m., for n = 4 independent 
experiments with triplicates per sample in each experiment (***P = 4.27 × 10−5). LTC-IC, long-term culture-initiating cell assay. c, Quantification of c.f.u. 
colonies grown from LSK and MS-5 co-cultures shown in b. Data represent the mean ± s.e.m., n = 3 independent experiments with triplicates per sample in 
each experiment (***P = 0.001). d,e, absolute numbers of CaR cells (CD45–CD31–Lin–PDGFRα+Sca1–) (d) and PαS cells (CD45–CD31–Lin–PDGFRα+Sca1+) 
(e) in the BM. Data represent the mean ± s.e.m., n = 16 Ebf1+/+Prx1Cre mice and n = 14 Ebf1fl/flPrx1Cre mice. f,g, Numbers (f) and frequency (g) of hSCs 
(CD135–CD48–CD150+LSK) in the BM. Data represent the mean ± s.e.m., n = 13 mice per group (***P = 0.0006, **P = 0.002). h, Percentage of annexin 
V–positive hSCs in the BM. Data represent the mean ± s.e.m., n = 8 Ebf1+/+Prx1Cre mice and n = 9 Ebf1fl/flPrx1Cre mice (***P = 0.0008). i, Percentage of hSCs 
within each cell cycle phase. Data represent the mean ± s.e.m., n = 8 Ebf1+/+Prx1Cre mice and n = 9 Ebf1fl/flPrx1Cre mice (**P = 0.009). j, Numbers of MPP3 
(CD135–CD48–CD150+LSK) and MPP4 (CD135+CD150–LSK) cells in the BM. Data represent the mean ± s.e.m., n = 15 (MPP3), n = 12 (MPP4) Ebf1+/+Prx1Cre 
mice and n = 16 (MPP3), n = 13 (MPP4) Ebf1fl/flPrx1Cre mice (***P = 0.0003). k, Numbers of neutrophils (CD11b+CD11c–Ly6G+), monocytes (CD11b+CD11c–
Ly6Chi) and macrophages (MhC-II+CD11b+F4/80+) in the BM. Data represent the mean ± s.e.m., n = 10 Ebf1+/+Prx1Cre mice and n = 13 Ebf1fl/flPrx1Cre mice 
(***P = 0.00006, **P = 0.002, *P = 0.01). l, Frequency of myeloid cells (Mac1+Gr1+) in the peripheral blood. Data represent the mean ± s.e.m., n = 16 mice 
per group (***P = 2.7 × 10−6). Statistical analysis in b–l was performed using a two-tailed unpaired Student’s t-test.
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number of HSCs in the BM of Ebf1fl/flNG2Cre-ER mice compared to 
control mice (Fig. 3f,g) and serial replating of BM cells showed a 
decreased capacity to form c.f.u. colonies, indicative of impaired 
HSC function (Fig. 3h). However, no significant changes were 
detected in other cell populations (Fig. 3i,j and Extended Data 
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Fig. 3 | Decreased numbers of HSPCs in animals with LepRCre and tamoxifen-inducible NG2Cre-ER-mediated deletion of Ebf1 in stromal cells. a, absolute 
numbers of hSCs (CD135–CD48–CD150+LSK) in the BM. Data represent the mean ± s.e.m., n = 15 Ebf1+/+LepRCre mice and n = 16 Ebf1fl/flLepRCre mice 
(**P = 0.006). b, Numbers of neutrophils (CD11b+CD11c–Ly6G+), monocytes (CD11b+CD11c–Ly6Chi) and macrophages (MhC-II+CD11b+F4/80+) in the BM. 
Data represent the mean ± s.e.m., n = 8 mice per group (*P = 0.03, **P = 0.005). c, Frequency of myeloid cells (Mac1+Gr1+) in the peripheral blood (PB). Data 
represent the mean ± s.e.m., n = 14 Ebf1+/+LepRCre mice and n = 16 Ebf1fl/flLepRCre mice (***P = 0.0004). d, Number and frequency of CaR cells (CD45–CD31–Lin–
PDGFRα+Sca1–) in the BM. Data represent the mean ± s.e.m., n = 13 Ebf1+/+LepRCre mice and n = 17 Ebf1fl/flLepRCre mice (***P = 0.0004, *P = 0.03). e, Number of 
PαS cells (CD45–CD31–Lin–PDGFRα+Sca1+) in the BM. Data represent the mean ± s.e.m., n = 13 Ebf1+/+LepRCre mice and n = 17 Ebf1fl/flLepRCre mice. f,g, Number 
(***P = 7.6 × 10−5) (f) and frequency (***P = 0.0002) (g) of hSCs in the BM. Data represent the mean ± s.e.m., n = 18 mice per group. h, Quantification of 
c.f.u. colonies upon serial replating of 3 × 104 BM cells. c.f.u. colonies were counted and replated in triplicate, every 7 d. Data represent the mean ± s.e.m. of 3 
independent experiments, n = 6 of Ebf1+/+ NG2Cre-ER mice and n = 7 Ebf1fl/flNG2Cre-ER mice (***P = 1.4 × 10−7, **P = 0.001, *P = 0.02). i, Numbers of myeloid cells 
in the BM. Data represent the mean ± s.e.m., n = 12 mice per group. j, Numbers of CaR cells and PαS cells in the BM. Data represent the mean ± s.e.m., n = 14 
Ebf1+/+ NG2Cre-ER mice and n = 16 Ebf1fl/flNG2Cre-ER mice. Statistical analysis in a–j was performed using a two-tailed unpaired Student’s t-test.
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of Ebf1, NG2-targeted inactivation of Ebf1 had no effect on myeloid 
cell differentiation, which is consistent with the dispensability of 
NG2-expressing stromal cells for myelopoiesis34. Thus, the proper 
maintenance of HSCs requires the function of EBF1 in the perivas-
cular niche, including arteriole pericytes.
Cell adhesion defects in Ebf1-deficient BM stromal cells. To 
gain insight into the mechanisms that underlie the phenotypes 
of Ebf1-deficient stromal cells, we performed RNA-seq on FACS-
sorted CAR and PαS cells from Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre  
mice. We identified 504 and 443 differentially expressed genes in 
Ebf1fl/flPrx1Cre CAR and PαS cells, respectively (Fig. 4a and Supple-
mentary Table 2). Among the genes that were significantly down-
regulated in Ebf1fl/flPrx1Cre stromal cells, we identified many genes 
associated with cell adhesion, cell–cell and cell–ECM interactions, 
cell migration, inflammatory responses and myeloid differentia-
tion (Fig. 4b and Supplementary Table 2). To functionally validate 
a potential adhesion defect in Ebf1-deficient MSCs, we performed 
three experiments. First, we used in vitro adhesion assays with LSK 
cells from wild-type mice and primary CAR and PαS cells from 
Ebf1+/+Prx1Cre or Ebf1fl/flPrx1Cre mice. Fewer LSK cells were able to 
attach to Ebf1-deficient stromal cells, compared to the control MSCs 
(Fig. 4c). Second, we examined the adhesion and migration poten-
tial of wild-type LSK cells in combination with wild-type CAR or 
PαS cells in which stromal EBF1-regulated genes had been knocked 
down. Decreased expression of Sell, which encodes L-selectin, in 
CAR and PαS cells resulted in reduced LSK adhesion and migra-
tion (Fig. 4d,e). Consistent with the important role of integrins in 
the retention of HSCs in the BM and in their interaction with the 
niche35,36, the knockdown of Itga6 or Itgb8 decreased the adhesion of 
LSKs but enhanced their migration toward the CAR cells (Fig. 4d,e). 
Moreover, knockdown of Ccl3 in PαS cells decreased the adhesion 
of LSKs to PαS cells but did not affect the migration capacity of LSKs 
(Fig. 4d,e). Third, we assessed the adhesion defect in vivo by inject-
ing Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice with granulocyte-colony 
stimulating factor (G-CSF), which induces the egress of HSPCs from 
the BM to the periphery35. Indeed, we detected increased numbers 
and frequencies of LSKs and HSCs in the spleens of Ebf1fl/flPrx1Cre 
mice, compared to the controls (Fig. 4f and Extended Data Fig. 5a). 
Taken together, these results show that EBF1 regulates a stromal cell 
adhesion program that is necessary to maintain a functional pool of 
HSCs in the BM.
To determine which of the deregulated genes are potential EBF1 
targets, we used ATAC-seq (assay for transposase-accessible chro-
matin with deep sequencing) coupled with digital footprinting of 
EBF1-binding sites as a substitute for an EBF1 ChIP-seq (chromatin 
immunoprecipitation sequencing), which requires a substantially 
higher number of cells. We identified 3,926 wild-type-specific 
and 6,558 knockout-specific ATAC peaks in CAR cells and 1,655 
wild-type-specific versus 4,841 knockout-specific ATAC peaks in 
PαS cells, located mainly near the cis-regulatory elements and pro-
moters (Fig. 4g and Extended Data Fig. 5b,c). The EBF motif was 
detected in 33.2% and 46.6% of the wild-type-specific targets in 
CAR and PαS cells, respectively (Extended Data Fig. 5d). Loss of 
EBF1 occupancy has been shown to result in diminished chroma-
tin accessibility in pro-B cells37,38. We identified potential EBF1 tar-
get genes by assigning each of the ATAC-seq peaks containing the 
EBF motif to the genes that have the transcriptional start site within 
100 kb of the peak (Supplementary Table 3). We also overlapped 
the EBF1 motif-associated ATAC peaks with the RNA-seq data and 
found that 29 genes (out of 504 genes) were differentially regulated 
in EBF1 knockout versus wild-type CAR cells, and that these 29 
genes contained wild-type-specific EBF1-associated ATAC peaks. 
In PαS cells, 12 out of 443 of deregulated genes showed altered chro-
matin accessibility near EBF1 motifs (Extended Data Fig. 5e).
To further refine the list of EBF1-regulated genes, we performed 
digital footprinting of EBF1 motif-associated ATAC sites in Ebf1+/+ 
and Ebf1–/– cells to assess the EBF1 occupancy. We identified 1,360 
wild-type-specific, 380 common and 591 knockout-specific EBF 
footprints in CAR cells, and similar numbers in PαS cells (Extended 
Data Fig. 5f). By overlapping the wild-type-specific digital EBF1 
footprints with the RNA-seq data sets, we identified 14 genes in 
CAR cells and 9 genes in PαS cells that were deregulated and that lost 
both EBF1 occupancy and chromatin accessibility (Extended Data 
Fig. 5e). In CAR and PαS cells, the genes that were identified include 
S100a8, Itgal, Lef1, Ccr7, Megf10 and Il1b (Fig. 4h, Extended Data 
Fig. 5e and Supplementary Table 3). Thus, a set of genes involved in 
cell adhesion and chemotaxis includes genes that are differentially 
regulated and are bound by EBF in CAR and PαS cells.
Reduced self-renewal of HSCs from Ebf1fl/flPrx1Cre mice. To assess 
whether HSCs from an Ebf1-deficient niche are functionally defec-
tive, we performed in vitro c.f.u. assays. Indeed, HSCs sorted from 
Ebf1fl/flPrx1Cre mice formed fewer c.f.u. colonies than did control 
HSCs (Fig. 5a). Additionally, BM cells from Ebf1fl/flPrx1Cre mice 
showed a reduced capacity to form c.f.u. colonies in serial replat-
ing experiments (Fig. 5b). We also examined the ability of HSCs 
from Ebf1fl/flPrx1Cre mice to give rise to myeloid and lymphoid prog-
eny in vitro. To this end, we sorted single HSCs from Ebf1+/+Prx1Cre 
and Ebf1fl/flPrx1Cre mice and differentiated them in methylcellulose 
Fig. 4 | transcriptome changes in CaR and PαS cells upon Ebf1 deletion. a, Scatter plots depict differentially expressed genes in bulk RNa-seq  
(>2-fold, P < 0.05) from CaR and PαS cells from Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice (n = 3 biologically independent samples per group). Upregulated 
genes are shown in red and downregulated genes are shown in green. axes represent the log2 scale of FPKM (fragments per kilobase of transcript per 
million reads). The differential gene expression between the conditions was calculated using Cuffdiff. The differentially expressed genes were filtered 
with the q value cutoff <0.05 following Benjamini–hochberg (FDR, false discovery rate) multiple testing correction of the original P values. b, heat maps 
show downregulation of cell adhesion and migration genes in Ebf1fl/flPrx1Cre CaR and PαS cells. c, In vitro adhesion of wild-type LSK cells to primary CaR 
or PαS cells from Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice. Static adhesion assay was carried out for 3 h. Data represent the mean ± s.e.m. from 3 independent 
experiments with n = 13 (CaR) and n = 13 (PαS) Ebf1+/+Prx1Cre mice, and n = 16 (CaR) and n = 9 (PαS) Ebf1fl/flPrx1Cre mice (**P = 0.0026, *P = 0.039).  
d, In vitro adhesion and transwell migration of wild-type LSK cells to primary, wild-type CaR or PαS cells with siRNa-mediated knockdown of indicated 
genes. Static adhesion or migration assays were carried out for 3 h. Data represent the mean ± s.e.m. from 5 independent experiments (*P < 0.05, 
**P < 0.01, ***P < 0.001). e, Relative mRNa expression levels of indicated genes, 48 h after transfection with siRNa targeting Sell, Itga6, Itgb8, Ccl3, Cxcl2 or 
a scrambled control (Ctr). Data are represented as the mean fold change ± s.e.m. over the scrambled control set as 1, for n = 3 independent experiments 
(*P < 0.05, **P < 0.01, ***P < 0.001). f, Frequency and absolute number of LSK cells in the spleens (SP) of Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice after G-CSF 
treatment. G-CSF was injected subcutaneously once a day for six consecutive days. Mice were analyzed on day 7 from the start of G-CSF treatment.  
Data represent the mean ± s.e.m., for 3 independent experiments, n = 7 mice per group (**P = 0.002). Statistical analysis in c–f was performed using  
a two-tailed unpaired Student’s t-test. g, Density maps show chromatin accessibility in CaR and PαS cells sorted form Ebf1+/+ and Ebf1–/– mice. aTaC 
signals are centered ±3 kb around the center of the peak. The heat map density is represented as the RPKM (reads per kilobase of transcript per million 
reads) mean score. h, Representative tracks show merged aTaC signal correlated with differentially expressed genes identified by RNa-seq. The scale on 
the y axis represents RPKM values in aTaC-seq.
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or liquid cultures containing myeloid- and lymphoid-promoting 
cytokines. Fewer c.f.u. colonies were generated from single HSCs 
of Ebf1fl/flPrx1Cre mice relative to HSCs from control mice (Fig. 5c). 
In single-HSC liquid cultures from Ebf1fl/flPrx1Cre mice, we also 
obtained fewer myeloid cells but similar frequencies of lymphoid or 
megakaryocytic cells (Fig. 5d).
To confirm this functional defect of HSCs in vivo, we competi-
tively transplanted 150 purified HSCs from Ebf1fl/flPrx1Cre or con-
trol mice into primary and secondary wild-type recipients. Notably, 
these HSCs are genetically wild type but have been exposed to a 
niche that lacks EBF1. Therefore, we could address whether the 
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phenotype. The overall chimerism and donor contribution to the 
HSCs, B cells and T cells in the BM and peripheral blood of pri-
mary recipients was similar for HSCs from Ebf1fl/flPrx1Cre and con-
trol mice (Fig. 5e,f and Extended Data Fig. 6a–d). Nevertheless, 
donor contribution into myeloid cells was decreased in the BM 
(Fig. 5f) and peripheral blood at weeks 8 and 16 after transplan-
tation compared to control mice (Extended Data Fig. 6b). The 
phenotype became progressively more severe in the secondary 
transplantations, for which we observed a multi-lineage engraft-
ment defect with decreased chimerism in the BM and peripheral 
blood (Fig. 5g and Extended Data Fig. 6a) and reduced donor 
contribution to HSCs and mature blood cells compared to control 
mice (Fig. 5h and Extended Data Fig. 6b–d). This transplantation 
phenotype could be the result of faster exhaustion of hematopoietic 
progenitors due to increased HSC proliferation in the Ebf1fl/flPrx1Cre 
mice. Indeed, cell cycle analysis of the progenitor compartment 
from the primary recipients showed enhanced proliferation poten-
tial compared to control mice (Fig. 5i). To assess a potential exhaus-
tion of HSCs, we subjected the mice to chronic myeloablation with 
Fluorouracil (5-FU). We observed an increase in the mortality of 
5-FU-treated Ebf1fl/flPrx1Cre mice, compared to 5-FU-treated con-
trols (Fig. 5j). These results demonstrate that HSCs that are exposed 
to the Ebf1-deficient niche exhibit diminished regenerative capac-
ity and reduced ability to generate myeloid cells, in comparison to 
controls, that persist even after re-introduction of the HSCs into a 
wild-type BM microenvironment.
Altered chromatin in HSCs from Ebf1-deficient niche. The 
impaired HSC function and decreased myeloid output in 
Ebf1fl/flPrx1Cre mice compared to control mice could be a consequence 
of two mechanisms. First, the epigenetic status of the chromatin that 
determines the access of transcription factors and lineage regula-
tors may be altered in HSCs. Second, a defective niche could cause 
selective skewing of certain subset of HSCs. To examine how the 
dysregulation of stromal cells impacts the chromatin landscape of 
HSCs, we performed ATAC-seq on HSCs sorted from Ebf1fl/flPrx1Cre 
and Ebf1+/+Prx1Cre mice. In the HSCs from the Ebf1-deficient niche, 
we identified 2,382 sites with diminished accessibility and 2,433 
sites with enhanced accessibility (Fig. 6a and Extended Data Fig. 7a). 
Motif discovery and digital genomic footprinting analysis identi-
fied motifs for ETS, AP-1, RUNX and IRF transcription factors in 
lost or diminished ATAC peaks (Fig. 6b and Extended Data Fig. 7b). 
As a control, no major difference in the digital footprint of the 
transcription factor CTCF was observed. Interestingly, all afore-
mentioned transcription factors have been implicated in HSC 
biology and myeloid differentiation39–43. We also compared motif 
co-occurrence clustering for the wild-type-specific versus knock-
out-specific digital footprints and found a co-occupancy of ETS 
and AP-1 motifs (Extended Data Fig. 7c). Recently, signal-induced 
AP-1 factors (c-Jun and c-Fos) have been found to be required for 
cell type-specific enhancer selection through a collaboration with 
lineage-specific ETS family proteins44. Collectively, our results show 
that HSCs exposed to an Ebf1-deficient niche cannot fully imple-
ment the myeloid differentiation program.
Next, we examined by RNA-seq analysis transcriptomic changes 
between HSCs that were exposed to a wild-type or Ebf1-deficient 
niche. We identified 78 upregulated and 59 downregulated genes in 
HSCs from Ebf1fl/flPrx1Cre mice, compared to the HSCs from control 
mice (Fig. 6c and Supplementary Table 4). Integration of the ATAC 
and RNA-seq data sets revealed a correlation of lost ATAC-seq 
peaks with dysregulated genes (Fig. 6d). Among the significantly 
dysregulated genes, we found regulators of cell proliferation (Egr2, 
Rps6ka6 and Cdkn1a), DNA damage (Mre11a, Nr4a2 and Rev3l), 
HSC maintenance and self-renewal (Upf2, Hes1, Smad7, Ints5 and 
Cdc42ep1) and mediators of the MAP kinase pathway (Rps6ka6, 
Dusp5 and Rps6ka4). More importantly, genes that are responsible 
for myeloid development were also markedly changed in HSCs 
from Ebf1fl/flPrx1Cre mice, including Ptgs2, Cd69, C1galt1 and Dpp4. 
In addition, a gene set enrichment analysis showed that genes that 
are involved in the positive regulation of the differentiation signa-
ture of myeloid cells are enriched in HSCs derived from the wild-
type niche (Extended Data Fig. 7d).
To explore whether the observed changes in the chromatin land-
scape of HSCs are maintained after transplantation into wild-type 
mice, we performed ATAC-seq on HSCs from Ebf1fl/flPrx1Cre mice 
after serial transplantations. We identified 69 sites with reduced 
chromatin accessibility that were retained in primary and secondary 
recipients (Fig. 6e and Supplementary Table 4). Sites with a persis-
tent decrease in the ATAC-sensitive signal were found to be in the 
proximity of genes that are involved in the DNA damage response 
(Fancc), chromosome segregation (Ubash3b), transcriptional reg-
ulation (Lhx9), and cell migration and adhesion (Arpc2) (Fig. 6f, 
Extended Data Fig. 7e and Supplementary Table 4). To examine 
the functional relevance of persistently decreased ATAC peaks, we 
Fig. 5 | transplantation of HSCs from Ebf1-deficient niche to wild-type recipients does not reverse reduced myeloid output. a, Quantification of 
c.f.u. colonies from 150 hSCs (CD135–CD48–CD150+LSK) sorted from Ebf1fl/flPrx1Cre and Ebf1+/+Prx1Cre animals. Data represent the mean ± s.e.m. for 3 
independent experiments, n = 9 Ebf1+/+Prx1Cre mice and n = 10 Ebf1fl/flPrx1Cre mice (***P < 0.001). b, Quantification of c.f.u. colonies upon serial replating of 
3 × 104 BM cells. c.f.u. colonies were counted and replated every 7 d, in triplicate. Data represent the mean ± s.e.m. for 3 independent experiments, n = 7 
Ebf1+/+Prx1Cre mice and n = 9 Ebf1fl/flPrx1Cre mice (***P = 2.2 × 10−6 for second, ***P = 4.9 × 10−9 for third, *P = 0.01). c, Percentage of wells, in 96-well plate, 
containing a c.f.u. colony grown from single-sorted hSC (CD135–CD48–CD150+LSK). Data represent the mean ± s.e.m. for 4 independent experiments, 
n = 17 Ebf1+/+Prx1Cre mice and n = 18 Ebf1fl/flPrx1Cre mice (***P = 8 × 10−5). d, Violin plot shows the frequency of granulocytes (Gr1hiMac1+), monocytes 
(Gr1loMac1+), total myeloid cell (Mac1+), B cells (CD19+) and megakaryocytes (CD41+) differentiated from single-sorted hSCs (CD135–CD48–CD150+LSK). 
White dot represents the median, black whiskers show the 25th (bottom) to the 75th (top) percentile, for 4 independent experiments with n = 222 hSCs 
from 12 Ebf1+/+Prx1Cre mice and n = 247 hSCs from 14 Ebf1fl/flPrx1Cre mice (P = 1 × 10−7 for Gr1hi and P = 5 × 10−7 for Mac1+ cells). e, Percentage of CD45.2+ 
donor-derived cells in the BM of primary recipients. Data represent the mean ± s.e.m. for 3 independent experiments, n = 19 Ebf1+/+Prx1Cre mice and 
n = 18 Ebf1fl/flPrx1Cre mice. f, Frequencies of donor-derived cells within hSCs (CD135–CD48–CD150+LSK), monocytes (monoc.) (Mac1+Gr1lo), granulocytes 
(granuloc.) (Mac1+Gr1hi), B cells (CD19+B220+) and T cells (CD3+) in the BM of the primary wild-type recipients, 16 weeks after transplantation (BMT). 
Data represent the mean ± s.e.m. for 3 independent experiments, n = 18 Ebf1+/+Prx1Cre mice and n = 16 Ebf1fl/flPrx1Cre mice (*P = 0.04, **P = 0.008).  
g, Percentage of CD45.2+ donor-derived cells in the BM of secondary wild-type recipients. Data represent the mean ± s.e.m. for 2 independent 
experiments, n = 20 Ebf1+/+Prx1Cre mice and n = 29 Ebf1fl/flPrx1Cre mice (***P = 1 × 10−7). h, Frequencies of donor-derived cells within hSCs (CD135–
CD48–CD150+LSK) (***P = 0.0008), monocytes (Mac1+Gr1lo) (***P = 1.7 × 10−7), granulocytes (Mac1+Gr1hi) (***P = 3.8 × 10−7), B cells (CD19+B220+) 
(***P = 0.0004) and T cells (CD3+) (*P = 0.01) in the BM of the secondary wild-type recipients, 16 weeks after transplantation. Data represent the 
mean ± s.e.m., for 2 independent experiments, n = 21 Ebf1+/+Prx1Cre mice and n = 29 Ebf1fl/flPrx1Cre mice. i, Percentage of hSCs from primary recipients within 
each cell cycle phase. Data represent the mean ± s.e.m. for 2 independent experiments, n = 10 Ebf1+/+Prx1Cre mice and n = 11 Ebf1fl/flPrx1Cre mice (**P = 0.002). 
Statistical analysis in a–i was performed using the two-tailed unpaired Student’s t-test. j, Kaplan–Meier survival curve of Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice 
following 10 intraperitoneal 5-FU injections every 10 d (n = 10 mice for Ebf1+/+Prx1Cre group and n = 12 mice for Ebf1fl/flPrx1Cre group).
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performed CRISPR–Cas9-mediated gene editing in wild-type LSK 
cells to delete such sequences in the proximity of the Fancc, Fanci, 
Kdm6b and Gas6 genes. The deletion of sequences associated with 
differential ATAC peaks in the Fancc and Gas6 loci decreased the 
expression of these genes, whereas the deletion of such a sequence 
in Kdm6b resulted in its increased expression (Fig. 6g). These results 
indicate that the sequences that underlie persistently altered ATAC 
peaks include regulatory elements that are important for correct 
gene expression.
Ebf1-deficient niche affects the cellular composition of HSCs. 
The limited number of stable changes in chromatin accessibility sug-
gested that additional mechanisms may account for the mutant phe-
notypes. To examine the possibility of an altered HSC composition 
in Ebf1fl/flPrx1Cre mice relative to Ebf1+/+Prx1Cre mice, we performed 
scRNA-seq on LSK progenitors. The clustering using RaceID3 
algorithm revealed 6 major clusters in the HSC (CD135–CD48–
CD150+) population (Fig. 7a). Interestingly, cluster 2 contained 
significantly more, and cluster 3 significantly fewer, cells from 
Ebf1fl/flPrx1Cre mice compared to controls (Fig. 7b–d and Supple-
mentary Table 5). In cluster 3, we observed an enrichment of mark-
ers that characterize quiescent HSCs (Fig. 7e,f, Extended Data Fig. 8a 
and Supplementary Table 5). These include EPCR (Procr), a marker 
of long-term HSCs, and Hlf, Ash1l, Egr1, Malat1 and Neat1, which 
are abundantly expressed in hematopoietic progenitors and which 
regulate HSC self-renewal45,46. Cdk6, which encodes a regulator of 
cell cycle progression and marker of activated HSCs47, was enriched 
in cluster 2. Notably, a substantial number of genes that were dif-
ferentially regulated between cluster 2 and cluster 3 also showed 
reduced chromatin accessibility in HSCs from Ebf1fl/flPrx1Cre mice 
compared to controls (Fig. 7g and Extended Data Fig. 8b). Thus, the 
Ebf1-deficient niche can shift HSCs from a quiescent state (cluster 3) 
to a more activated state (cluster 2), which is consistent with our 
functional experiments. In cluster 10, we observed an enrichment 
of cells from Ebf1fl/flPrx1Cre mice that express the myeloid lineage 
markers Mpo and Ctsg and that may represent myeloid progenitors 
(Extended Data Fig. 8c–g and Supplementary Table 5). Cluster 10 
showed reduced expression of many ribosomal genes as compared 
to cluster 11 (Extended Data Fig. 8g and Supplementary Table 5). 
This result suggests that the Ebf1-deficient niche may lead to the 
accumulation of progenitors with reduced translational capacity 
and diminished myeloid differentiation potential. Thus, an Ebf1-
deficient BM niche affects HSC function by an altered cellular com-
position and chromatin landscape.
Discussion
The importance of stromal cells for hematopoiesis is well estab-
lished. However, most research efforts aimed at understanding the 
underlying mechanisms have focused on factors that are secreted by 
the niche and that regulate HSC maintenance in an exocrine man-
ner6,13,14,16. In contrast, the transcriptional networks governing the 
biology of MSCs remain largely elusive. Members of the EBF fam-
ily of transcription factors have been implicated in the function of 
MSCs22,24. We find that Ebf1 is expressed in both CAR and PαS cells, 
whereas Ebf2 is expressed in a small set of PαS cells, and Ebf3 tran-
scripts are detected specifically in CAR cells. The comparison of the 
phenotypes of stromal deletions of Ebf genes suggest unique, as well 
as partially redundant functions. In particular, Ebf3fl/flPrx1Cre mice 
show a marked increase in trabecular bone mass and associated 
loss of BM cavities, which is enhanced by a combined deletion of 
Ebf1 (ref. 24). The progressive osteosclerosis caused by an enhanced 
osteoblast differentiation in Ebf3-deficient mice makes it difficult to 
interpret the severe hematopoietic defect. By using three different 
mouse models for stromal deletion of Ebf1, we consistently found 
reduced numbers of HSCs and functional defects that are greatly 
enhanced in secondary transplantations.
The bulk and single-cell transcriptome analyses of CAR and PαS 
cells that lack Ebf1 revealed the diminished expression of multiple 
genes that encode regulators and components of cell adhesion and 
migration. By intersecting the transcriptome data sets with data from 
ATAC-seq and digital footprint analysis, we identified genes that 
are directly regulated by EBF1, and that include several integrin and 
chemokine genes known to mediate adhesion and stem cell-niche 
interactions36,10. For several of these genes, including integrins, we 
could functionally validate their role in supporting the adhesion of 
LSKs in vitro and in vivo. Integrin signaling has an important role 
in the retention of HSCs or progenitors in the BM but it remains 
unclear how Cxcl12–Cxcr4 signaling, which activates integrins, 
mediates stem cell quiescence35. The interaction of HSCs with their 
microenvironment is also essential to assure the integrity of the HSC 
pool. Thus, the impaired cell adhesion properties of Ebf1-deficient 
MSCs may account for the increased proliferation and apoptosis of 
HSCs, which may lead to reduced numbers of HSCs by exhaustion. 
Moreover, interactions of hematopoietic progenitors with specific 
stromal cells are also important for lineage priming34,48. Hence, the 
changes in the composition of stromal cells in the Ebf1fl/flPrx1Cre 
mice may contribute to the reduced myeloid lineage output.
Most notably, our data indicate that HSCs from the Ebf1-deficient 
niche lose their self-renewal capacity and myeloid lineage output 
and ‘remember’ this phenotype even after a transfer into a wild-type 
niche. Concomitant changes in chromatin accessibility and/or HSC 
heterogeneity could account for this phenotype and are reminis-
cent of the concept of niche-induced reprogramming of HSCs. This 
concept is also clinically relevant. Cases of donor-derived blood 
disorders in patients after BM transplants could be the conse-
quence of a malfunctioning niche in the host49,50 that will eventually 
Fig. 6 | Niche-dependent changes in HSC chromatin accessibility and transcriptome. a, Density map shows chromatin accessibility in hSCs sorted 
from Ebf1fl/flPrx1Cre and control animals. aTaC signals merged from duplicates are centered ±3 kb around the center of the peak. The heat map density is 
represented as the RPKM mean score. b, Digital genomic footprinting analysis shows average normalized Tn5 insertion profiles around footprinted motifs 
in merged aTaC peaks. Insertions on the forward and reverse strands are indicated in red and blue, respectively. c, Volcano plot displaying differentially 
expressed genes (>twofold, P < 0.05) in hSCs sorted from Ebf1fl/flPrx1Cre and control mice (n = 2 biologically independent samples per group). Upregulated 
genes are colored in red and downregulated genes are colored in green; FC, fold change. The differential gene expression between the conditions was 
calculated using Cuffdiff. The differentially expressed genes were filtered with the q value cutoff of <0.05 following Benjamini–hochberg multiple testing 
correction of the original P values. d, Representative tracks show the merged aTaC signal correlation with upregulated gene (DPP4) and downregulated 
gene (Rps6ka6). The scale on the y axis represents RPKM values in aTaC-seq and RNa-seq tracks. e Density plot shows sites with reduced chromatin 
accessibility retained between hSCs from original donor mice and primary and secondary recipients. aTaC signals merged from the replicates of each 
experiment are centered ±3 kb around the center of the peak. The heat map density is represented as the RPKM mean score. f, Representative tracks 
show the merged aTaC signal corresponding to the density maps shown in e. The scale on the y axis represents RPKM values. g, CRISPR–Cas9-mediated 
deletion of DNa sequences with reduced aTaC signal identified in e and f. Graph represents relative mRNa expression levels of depicted genes in sorted 
GFP+ LSK cells, 24 h after electroporation with plasmid containing gRNa targeting DNa sequences within or in proximity of the Fancc, Fanci, Kdm6b and 
Gas6 genes (CRISPR) or with a control plasmid (CTR). Data are represented as the mean FC ± s.e.m. over empty control plasmid (CTR) set as 1, for n = 4 
independent experiments (*P = 0.04 for Fancc and Gas6, *P = 0.033 for Kdm6b).
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Fig. 7 | Niche-dependent changes in HSC composition. a, t-SNE map shows clusters of cells with similar transcriptomes within the hSC (CD135–CD48–
CD150+LSK) population, derived by the RaceID3 algorithm. Data represent 1,333 single-sorted cells from 2 independent experiments (n = 5 mice for the 
Ebf1+/+Prx1Cre group and n = 6 mice for the Ebf1fl/flPrx1Cre group). b, t-SNE map shows the distribution of hSCs from Ebf1+/+Prx1Cre mice (gray) and hSCs from Ebf1fl/fl 
Prx1Cre mice (blue) within established clusters. c, t-SNE map shows clusters with statistically significant enrichment of hSCs from wild-type niche (cluster 3) 
or hSCs from Ebf1-deficient niche (cluster 2). d, Number of cells analyzed in each cluster that correspond to a and that are derived from a Fisher’s exact test. 
**P < 0.01 (exact P values and cell numbers for each cluster are provided in Supplementary Table 5). **P < 0.01. e, heat map shows genes that are differentially 
expressed between cluster 2 and cluster 3. The scale represents the log2-transformed normalized expression of genes (rows) across the cells in each cluster 
(columns). The color code of clusters corresponds to that used in c. f, t-SNE maps highlight the normalized expression of quiescence markers, such as Malat1, 
Procr, Hlf and Neat1 in sequenced hSCs. g, Representative tracks show the differential merged aTaC signal, highlighted by boxes, in hSCs from Ebf1+/+Prx1Cre and 
Ebf1fl/flPrx1Cre mice, correlated with genes that are differentially expressed between cluster 2 and cluster 3 (e). a region on chromosome 8 with Pcm1 and Asah1 
serves as a control without differential aTaC signal. The scale on the y axis represents RPKM. Black boxes and vertical lines below the tracks indicate exons. 
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permanently alter the healthy, transplanted HSCs. Therefore, it 
will be important to further investigate the mechanisms by which 
altered BM stroma affects the function and composition of HSCs.
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Methods
Mice. Ebf1+/− and Ebf1fl/fl mice were generated as described previously51. Prx1Cre, 
LepRCre and NG2Cre-ER mice were purchased from The Jackson Laboratory. With the 
exception of Ebf1−/− mice, all strains were maintained on the C57BL/6 background. 
Owing to perinatal mortality of Ebf1−/− mutants on the C57BL/6 background, 
Ebf1−/− animals were obtained by breeding Ebf1+/− mice (C57BL/6) to 129/Sv mice. 
Ebf1+/− F1 animals from those crosses were further intercrossed and the Ebf1−/− F2 
generation was used for experiments. To induce NG2Cre-ER-mediated recombination, 
6–8-week-old Ebf1fl/flNG2Cre-ER mice were treated with 5 mg of tamoxifen by oral 
gavage on days 1, 2, 4, 5 and 8. The animals were analyzed 6 weeks after tamoxifen 
administration. Unless indicated otherwise, 8–14-week-old male and female mice 
were used for experiments. All mice were bred in the animal facility of the Max 
Planck Institute of Immunobiology and Epigenetics under specific pathogen-free 
conditions. All animal procedures were performed according to protocols approved 
by the German authorities and the Regional Council of Freiburg.
BM transplantation. Transplantations were performed using the CD45.1/CD45.2  
congenic system. Recipient mice (8–10 weeks old) were lethally irradiated 
with 9.5 Gy (in a split dose: 5 Gy + 4.5 Gy, at least 3 h apart) using a gamma 
irradiator with a 137Cs source (Biobeam GM 8000). Purified donor cells together 
with competitive BM cells were injected into the tail vein and hematopoietic 
reconstitution was monitored over time in peripheral blood. Adoptive transfer into 
wild-type (CD45.1+) primary recipients was performed with 150 FACS-purified 
HSCs from Ebf1fl/flPrx1Cre and Ebf1+/+Prx1Cre mice (CD45.2+) together with 0.5 × 106 
of CD45.1+ competitive BM cells. Adoptive transfer into wild-type (CD45.1+) 
secondary recipients was performed using 3 × 106 cells from complete BM from the 
primary recipients.
G-CSF mobilization and 5-FU treatment. Mice were injected subcutaneously 
with G-CSF (Granocyte, Chugai Pharma Germany GmbH) at 250 μg kg−1  
(in 100 μl PBS) once a day for 6 consecutive days. Mice were analyzed at day 7  
from the start of G-CSF treatment.
5-FU was administered intraperitoneally at 150 mg kg−1 dose every 10 d.
Flow cytometry and cell sorting. Intact bones (femora and tibia) were chopped 
into small fragments and crushed in FACS buffer (PBS–2% FCS) using a pestle 
and mortar. BM cells were collected and red blood cell (RBC) lysis was performed. 
Next, the cells were washed with FACS buffer and were stained for analysis. For 
FACS sorting of HSPCs the cells were enriched by magnetic depletion. In brief, 
the BM cells were labeled with a cocktail of biotinylated antibodies (CD3, CD19, 
B220, CD11b, Gr1 and Ter119) and then with streptavidin-conjugated magnetic 
nanobeads (BioLegend). For non-hematopoietic BM cell isolation, the bone chips 
were digested with 0.3% collagenase type II and 0.02% DNase I at 37 °C for 45 min 
with gentle shaking. After enzymatic digestion, the cells were filtered, washed with 
FACS buffer, and stained accordingly. The BD FACSAria Fusion flow cytometer 
(BD Biosciences) was used for FACS sorting and the BD LSRFortessa cell analyzer 
was used for flow cytometry. Data were analyzed with FlowJo software (Tree Star).
c.f.u.-F and in vitro differentiation. Sorted PαS cells (1 × 103) or sorted CAR 
cells (3–5 × 103) were plated in 35-mm tissue culture plates in α-MEM medium 
supplemented with 15% FCS (Gibco), 10% MesenCult stimulatory supplement 
(Stemcell Technologies) and 1% penicillin–streptomycin (Gibco). Half of the 
medium was changed after 7 d of culture. The cells were stained with Giemsa 
staining solution (Sigma-Aldrich) and c.f.u.-F colonies were counted on day 14. 
For mesenchymal in vitro differentiation, single c.f.u.-F colonies were digested 
with 0.25% Trypsin-EDTA using cloning cylinders (Millipore), subcloned 
into three separate cultures in 48-well plates and expanded for an additional 
7–10 d. Adipogenic, osteogenic and chondrogenic differentiation was induced 
with StemPro differentiation kits (Invitrogen) according to the manufacturer’s 
instructions. All cultures were maintained at 37 °C and 5% CO2 and a half-medium 
change was performed twice a week. Adipocytes, osteoblasts and chondrocytes 
were identified by staining with oil red O (Sigma-Aldrich), alizarin red S (Sigma-
Aldrich) and toluidine blue O (Sigma-Aldrich), respectively. Cells under all 
staining conditions were washed with PBS and fixed with buffered formalin 
(10%) for 1 h. After rinsing with distilled water, adipocytes were stained with 0.3% 
solution of oil red O for 1 h, osteoblasts were stained with 2% alizarin red solution 
at pH 4.2 for 1 h and chondrocytes were stained with 0.1% toluidine blue solution 
at pH 2.4 for 45 min.
Histomorphometric analysis. Histomorphometric analysis was performed at 
the Skeletal Analysis Laboratories at the Medical School of The University of 
Sheffield. Tibiae were fixed in 10% formalin and decalcified in EDTA pH 7 for 
35 d. Following processing and embedding of the tibiae longitudinally in paraffin 
wax, 3 μm sections were cut at 2 tissue levels on SuperFrost Plus slides (Thermo 
Fisher Scientific), stained with hematoxylin and eosin and examined under light 
microscopy at ×20 magnification. Static histomorphometry measurement of 
trabecular and endocortical bone surfaces, osteoblast number and osteoblast 
surface was performed using OsteoMeasure bone histomorphometry software 
(OsteoMetrics). Active osteoblasts were identified as groups of three or more 
cuboidal cells lining the endocortical and trabecular surfaces. The number of 
osteoblasts per mm and the percentage of bone surface covered by osteoblasts were 
measured on 3.6 mm of the endocortical surfaces. Trabecular bone surfaces in a 
tissue area of 0.54 mm2 were measured for the number of osteoblasts per millimeter 
and the percentage of bone surface covered by osteoblasts.
Cell culture and RNA interference. MS-5 cells were kindly provided by E. Dzierzak 
(University of Edinburgh Medical School, UK). MS-5 cells were grown at  
37 °C and 5% CO2 in α-MEM medium supplemented with 10% FCS and 1% 
penicillin–streptomycin–ʟ-glutamine. Subconfluent MS-5 cells were transfected 
with 25 nM of ON-TARGETplus SMARTpool siRNA (Horizon) against mouse 
Ebf1 (L-045017-01) or ON-TARGETplus Non-targeting Pool (D-001810-10) as a 
control, according to the manufacturer’s instructions. Transfections were carried 
out in MS-5 cell culture medium without antibiotics, using DharmaFECT 1 
transfection reagent (Horizon).
Long-term culture-initiating cell assay. To prepare stromal layers, the MS-5 
cells were plated in 35-mm culture dishes and transfected with siRNA. Forty-
eight hours after transfection, MS-5 stromal cells were seeded with 1,500 sorted 
wild-type LSK cells per plate in MyeloCult medium (Stemcell Technologies) 
supplemented with 10 μM hydrocortisone (Stemcell Technologies) and 1% 
penicillin–streptomycin. Half of the medium was changed weekly and the cultures 
were maintained at 33 °C and 5% CO2. Cobblestone colonies, containing more than 
20 cells, were counted after 5 weeks of culture. Next, all cultures were trypsinized 
and plated in MethoCult M3434 (Stemcell Technologies), in technical triplicates. 
Cultures were maintained at 37 °C and 5% CO2 and c.f.u. colonies were enumerated 
after 14 d.
c.f.u. assay. In total, 150 FACS-sorted HSCs (CD135–CD48–CD150+LSK) were 
plated in MethoCult M3434 medium (Stemcell Technologies) in triplicate. 
c.f.u. colonies were counted at days 10–12. For the c.f.u. assays from spleen 
and peripheral blood, a single-cell suspension was prepared and the cells were 
subjected to RBC lysis. Then, 3 × 105 cells were plated in triplicate in MethoCult 
M434 medium. c.f.u. colonies were counted at day 14. Serial replating experiments 
were performed with 3 × 104 full BM cells after RBC lysis, in triplicate. c.f.u. 
colonies were counted at day 7, then cultures were washed three times with PBS 
and 3 × 104 cells were plated again in MethoCult M434 medium in triplicate.  
All cultures were maintained at 37 °C and 5% CO2.
HSC liquid cultures. Single HSCs (CD135–DC48–CD150+CD34–LSK) were sorted 
into U-bottom 96-well plates containing StemSpan SEFM medium (Stemcell 
Technologies) supplemented with 10% FCS (Gibco), 1% penicillin–streptomycin 
(Gibco) and cytokines mSCF (50 ng ml−1), mFlt3L (10 ng ml−1), mTPO  
(10 ng ml−1), mIL-3 (5 ng ml−1), mIL-11 (10 ng ml−1), mIL-7 (22 ng ml−1) and 
mGM-CSF (10 ng ml−1). All cytokines were purchased from PeproTech.  
Cultures were maintained at 37 °C and 5% CO2 and were analyzed by flow 
cytometry after 10–12 d.
In vitro adhesion and migration assay. FACS-sorted CAR and PαS cells were 
plated in 48-well tissue culture plates for the adhesion assay or in 24-well tissue 
culture plates for the migration assay in α-MEM supplemented with 15% FCS 
(Gibco), 10% MesenCult stimulatory supplement (Stemcell Technologies) and 
1% penicillin–streptomycin (Gibco) and were expanded for 7–10 d. In the case of 
siRNA-mediated knockdown experiments, subconfluent CAR and PαS cells were 
transfected with 50 nM of ON-TARGETplus SMARTpool siRNA against mouse 
Sell (L-042253-01), Itga6 (L-040204-01), Itgb8 (L-066709-01), Ccl3 (L-044189-00), 
Cxcl2 (L-045205-00) or ON-TARGETplus Non-targeting Pool (D-001810-10) as a 
control, according to the manufacturer’s instructions. Transfections were carried 
out in cell culture medium without antibiotics, using DharmaFECT 1 transfection 
reagent. In vitro adhesion and migration was performed 48 h after knockdown. 
Subsequently, FACS-sorted wild-type LSK cells were added to a monolayer of 
stromal cells and were allowed to adhere for 3 h at 37 °C and 5% CO2 in StemPro-34 
SFM medium with accompanying supplement (Gibco). After incubation, the non-
adherent LSK cells were collected, plates were washed once with PBS and adherent 
cells were detached with trypsin. Both fractions were stained with CD45 antibody 
and analyzed by flow cytometry. In the case of the migration experiment, FACS-
sorted wild-type LSK cells were added to the transwell and were allowed to migrate 
for 3 h at 37 °C and 5% CO2 in StemPro-34 SFM medium with supplement (Gibco). 
After incubation, all LSK cells from the lower chamber were collected, stained with 
CD45 antibody and analyzed by flow cytometry. Transwells with 6 μm pore size 
were used for experiments (Corning, cat. no. 3421).
Cell cycle analysis and annexin V staining. HSPCs were isolated using magnetic 
depletion of lineage-positive cells with the Mouse Hematopoietic Progenitor 
Isolation Kit (Stemcell Technologies) according to the manufacturer’s protocol. 
HSC surface staining (CD135–DC48–CD150+CD34–LSK) was performed on 
the enriched cells. For cell cycle analysis, the cells were fixed and permeabilized 
for 30 min at 4 °C with the eBioscience Foxp3/Transcription Factor Staining Kit 
(Invitrogen). Subsequently, intracellular Ki67 (eBioscience) staining was performed 
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for 30 min at 22 °C and Hoechst 33342 (Invitrogen), at 1 μg ml−1, was added  
for 10 min prior to flow cytometry analysis. For apoptosis assays, the cells were 
stained with the Annexin V Apoptosis Detection Kit (BD Pharmingen) according 
to the manufacturer’s guidelines. Samples were analyzed by flow cytometry  
within 30 min.
RNA extraction and real-time quantitative PCR. Total RNA was isolated with 
TRIzol Reagent (Ambion Life Technologies) according to the manufacturer’s 
instructions. Isolated RNA samples were treated with DNase (Promega). 
Complementary DNA (cDNA) was synthesized with the SuperScript II Reverse 
Transcriptase Kit (Invitrogen) and real-time quantitative PCR was performed 
with the Fast SYBR Green Master Mix (Applied Biosystems) according to the 
manufacturer’s guidelines. All of the samples were assayed in duplicate and were 
analyzed with a Step One Plus Real-Time PCR System (Applied Biosystems). 
Supplementary Table 6 contains a full list of the primer sequences.
Bulk RNA-seq and data analysis. Total RNA was prepared using the RNeasy 
Micro Kit (Qiagen) according to manufacturer’s instructions. mRNA was enriched 
by using oligo-dT magnetic beads for library preparation. The paired-end RNA-seq 
data sets were mapped to the mouse reference genome (UCSC genome browser, 
mm10) using TopHat (v2.0.14) and Bowtie (v2.2.6.0) (ref. 52). The mapped reads 
were further assembled by using Cufflinks (v2.2.1) and the expression level of the 
annotated genes (mm10) was calculated by Cuffquant53. The biological replicates 
of each condition were normalized and the differential gene expression between 
the conditions was calculated using Cuffdiff. The differentially expressed genes 
were filtered with the q value cutoff <0.05 following Benjamini–Hochberg multiple 
testing correction of the original P values. The gene sets were further filtered for 
more than twofold upregulation or downregulation in knockout relative to wild-
type cells. The reads were normalized to one million reads to visualize the RNA-
seq profiles by using the UCSC genome browser. Three biological replicates were 
used for RNA-seq from CAR and PαS cells with 1–1.2 × 104 PαS cells per replicate 
and 4–4.5 × 104 CAR cells per replicate. Duplicates were used for RNA-seq from 
HSCs with 1–1.5 × 104 cells per replicate.
Single-cell RNA-seq. The cells were sorted on a BD FACSAria Fusion cell sorter 
into 384-well plates (see Supplementary Methods). Amplified RNA was prepared 
from single cells using the CEL-Seq2 protocol, as described previously54, but 
which was adapted for use with a nanoliter pipetting robot (mosquito HTS, TTP 
Labtech) 29,55. The amplified RNA was reverse-transcribed to generate libraries for 
sequencing, as previously described54. Libraries were sequenced on an Illumina 
HiSeq 2500 System in high output run mode at a depth of ~200,000 reads per 
cell. For the quantification of transcript abundance, paired-end reads were 
aligned to the transcriptome using BWA (v0.6.2-r126) with default parameters56. 
The transcriptome contained all gene models based on the mouse ENCODE 
VM9 release that was downloaded from the UCSC genome browser and that 
comprised 57,207 isoforms, of which 57,114 isoforms mapped to fully annotated 
chromosomes (1 to 19, X, Y and M (mitochondrial DNA)). All isoforms of the 
same gene were merged to a single gene locus and gene loci were merged to larger 
gene groups, if loci overlapped by >75%. This procedure resulted in 34,111 gene 
groups. The right mate of each read pair was mapped to the ensemble of all gene 
groups and to the set of 92 External RNA Controls Consortium spike-ins in the 
sense direction. Reads mapping to multiple loci were discarded. The left mate of 
each read pair contains the barcode information: the first six bases corresponded 
to the cell specific barcode followed by six bases that represented the unique 
molecular identifier. The remainder of the left read contains a poly(T) stretch  
and adjacent gene sequence. The left read was not used for quantification. For  
each cell barcode and gene locus, the number of unique molecular identifiers  
was aggregated and, on the basis of binomial statistics, was converted into 
transcript counts57.
RaceID3 analysis of BM niche cells. Data from cells with high expression (>2% 
of all transcripts) of Kcnq1ot1, a marker for low quality cells28, were removed from 
the data before further processing by RaceID3. Moreover, data from transcripts that 
correlated to Kcnq1ot1 or to any of the genes Gm10715, Gm42418 or Gm10800 with 
a Pearson’s correlation coefficient of >0.65 were also removed. Reads that mapped 
to the External RNA Controls Consortium spike-ins were discarded. RaceID3 
was run on the data set with the following parameters: mintotal = 2500, cln = 14, 
downsample = FALSE, minexpr = 4, outminc = 4, FSelect = TRUE, probthr = 10−4 
and random forests-based reclassification. To remove batch and cell cycle variability, 
CGenes was initialized with the following genes: Pcna, Mki67, Jun and Fos. FGenes 
was initialized with Malat1, Xist, Kcnq1ot1, Gm26870, Gm10717, Gm10719 and 
Gm10800, as these genes were expressed across unrelated cell types. Enrichment 
for wild-type or Ebf1 knockout cells in every cluster was assessed using the Fisher’s 
exact test. Differential gene expression between two clusters was performed using 
the function diffexpnb from the FateID R package2 (CRAN) (ref .29).
Chromatin accessibility assay. ATAC-seq was performed as described previously58.  
To prepare nuclei, 1–2 × 104 cells were resuspended in 50 μl of cold lysis  
buffer (10 mM Tris·Cl at pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% [v/v] Igepal 
CA-630) and incubated for 15 min on ice. The supernatant was discarded after 
centrifugation, and the nuclei were used for the transposition reaction immediately. 
Duplicates were used for ATAC-seq from CAR and PαS cells with 1 × 104 PαS 
cells per replicate and 3–3.5 × 104 CAR cells per replicate. Duplicates were used 
for ATAC-seq from HSCs from donor Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice with 
1–1.5 × 104 cells per replicate. Three biological replicates were used for HSCs from 
primary recipients of Ebf1+/+Prx1Cre cells with 2 × 104 HSCs per replicate. Two 
biological replicates were used for HSCs from primary recipients of Ebf1fl/flPrx1Cre 
cells with 2 × 104 HSCs per replicate. Three biological replicates were used for 
HSCs from secondary recipients with 1 × 104 cells per replicate.
Chromatin accessibility data analysis. The Illumina sequencing reads were 
trimmed using Trim Galore! (v0.4.0), which is a wrapper for the Cutadapt (v1.8.1) 
tools. The trimmed reads were mapped to the mouse genome (mm10) using 
bowtie2 (v2.2.8) with the default settings59. The duplicated reads were removed 
using Picard tools (v1.136). The reads that mapped to blacklisted regions or the 
mitochondrial genome, and reads with mapping below 30 were removed by using 
programs that are available in Samtools60 and bedtools61. The properly mapped 
reads were used for identifying peaks by MACS2 (v2.1.1) (ref. 62) with the extsize 
125 and a q value cut off of 0.01. Peaks were further filtered for a P value cutoff 
of 10–7 to overlap the peaks. The peaks were organized into three groups, using 
bedtools, on the basis of the overlaps observed between wild-type and knockout 
cells. The heatmap of the ATAC signal, in knockout and wild-type cells, was 
visualized using deepTools63. The heatmap density represents the RPKM value with 
the bin size set at 50 bp. The ATAC peaks clusters were further filtered with the  
P value cutoff 10–10 for the motif enrichment analysis. For HSC ATAC-seq data 
sets, clusters were defined as displaying a log2 knockout or wild-type tag count fold 
change (FC) of ≤−1 (down), −1 < FC < 1(shared) or FC ≥ 1 (up) ±200 bp from 
the ATAC summit. The motifs were identified using HOMER software with default 
parameters64. The EBF motif-associated ATAC peaks with the P value cut off of 10–7 
were annotated by using HOMER (v4.7) to study the distribution of the peaks in 
the genomic context. The ATAC peaks were assigned to the genes that were present 
within 100 kb from the transcription start site. All of the data sets were normalized 
to one million reads, using bedtools, and each individual locus was visualized. 
For analyses concerning maintained peak trends between original, primary and 
secondary transplanted cells, peaks from the original HSC wild-type-only cluster 
were intersected with wild-type peaks from primary and secondary transplanted 
HSCs using bedtools intersect, excluding knockout peaks from primary and 
secondary transplanted HSCs using bedtools intersect -v.
Digital genomic footprinting. To attain a read depth of >100 million reads, 
replicates of ATAC-seq experiments were first merged at the bam file level using 
Samtools merge60 and were subsequently sorted and indexed using Samtools sort 
and Samtools index, respectively. Peak calling on merged files was performed using 
MACS2 (ref. 62). The resulting narrowpeak files were converted to the bed3 format 
using the bash command cut -f3. Digital genomic footprinting was performed 
using the wellington footprints command of the Wellington package65 on bed3-
converted peaks from combined replicates, using sorted and indexed bam files, 
with the ATAC -A switch, which results in the reference being shifted by −4 bp 
and +5 bp for the forward and reverse strands, respectively, owing to the double, 
9-bp-spaced nature of insertions by Tn5 dimers66. Footprints that had a P value 
lower than or equal to 10−10 were retained. For average insertion profiles per motif, 
the union of all footprints was first computed by merging all footprints using the 
following command: cat <footprints>| bedtools sort -i | bedtools merge –i –d  
20. Motifs were mapped to footprints via the HOMER annotatePeaks64 command 
using -m –mbed <bed file>-size given switches. Average insertion profiles were 
obtained using the dnase_average_profiles command of the Wellington package, 
using -n -A as parameters. Co-occurrence enrichment clustering analyses were 
performed exactly as previously described for footprints42, using footprints and 
motifs from this study.
CRISPR–Cas9 deletion. To generate gRNA for deletion of sequences underlying 
ATAC peaks, pSpCas9(BB)-2A–GFP (PX458) plasmid was used (Addgene plasmid, 
cat. no. 48138). gRNAs were designed using the CHOPCHOP tool67 (sequences 
of qRNAs are provided in Supplementary Table 6). gRNAs were cloned into 
pSpCas9(BB)-2A–GFP (PX458) plasmid according to the instructions provided 
in ref. 68 and cloning results were confirmed by sequencing (primer sequence 
provided in Supplementary Table 6). HSPCs were enriched by magnetic depletion. 
In brief, the BM cells from wild-type C57BL/6 mice were labeled with a cocktail 
of biotinylated antibodies (CD3, CD19, B220, CD11b, Gr1 and Ter119) and then 
with streptavidin-conjugated magnetic nanobeads (BioLegend). Enriched lineage 
negative cells (4 × 106) were electroporated using P3 Primary Cell 4D-Nucleofector 
Kit L (Lonza) with a total of 4 μg of PX458 plasmids containing gRNAs or 4 μg of 
PX458 empty plasmid as a control. Cells were maintained for 24 h at 37 °C and 5% 
CO2 in StemPro-34 SFM medium (Gibco) supplemented with 10% FCS (Gibco), 
1% penicillin–streptomycin (Gibco) and cytokines mSCF (50 ng ml−1) and mFlt3L 
(10 ng ml−1). Green fluorescent protein (GFP)-positive LSK cells were sorted using 
the BD FACSAria Fusion and RNA was prepared using an RNeasy Micro Kit 
(Qiagen) according to the manufacturer’s instructions. The deletion was confirmed 
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by PCR from genomic DNA that was obtained from sorted GFP+ cells using 
primers spanning the deleted region (primer sequences provided in  
Supplementary Table 6).
Statistical analysis. Statistical analysis was performed using the two-tailed 
unpaired Student’s t-test (confidence interval of 95%) with significance of P < 0.05, 
P < 0.01, P < 0.001. Pearson correlation coefficients were calculated using a 
confidence interval of 95%, two-tailed.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the 
corresponding authors upon request. Source data for Extended Data Fig. 1d are 
provided with the paper. All high-throughput data in this study were deposited 
at the Gene Expression Omnibus (GEO) under series GSE127970 (CAR, PαS 
RNA-seq and ATAC-seq), series GSE128089 (HSC RNA-seq and ATAC-seq), 
and series GSE128743 (single-cell RNA-seq). A web application for scRNA-seq 
data visualization is available at https://hematopoietic-niche-regulation-by-ebf1.
ie-freiburg.mpg.de.
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Extended Data Fig. 1 | See next page for caption.
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Extended Data Fig. 1 | Ebf1 deficiency alters MSC composition and gene expression. a, Representative gating strategy used to identify and isolate CaR 
and PaS cells. b, heat map depicting log2-transformed normalized expression of signature genes (rows) across the cells in each cluster (columns). Key 
genes are indicated on the right. Color code of clusters corresponds to Fig.1a. all clusters were compared in a pairwise fashion against each other and 
differentially expressed genes (adjusted P-value<0.05) appearing in at least 3 comparisons. Data represent 912 single-sorted wild-type cells from 3 
independent experiments (n=4 mice). Negative binomial distributions reflecting the gene expression variability within each subgroup were inferred, based 
on a background model for the expected transcript count variability, a P-value for the observed difference in transcript counts between the two subgroups 
is computed as described for DESeq2. The P-values were corrected for multiple testing via the Benjamini–hochberg method. c, t-SNE maps showing 
normalized expression of Ptprc, Rag1 and J chain in sequences CaR (CD45–CD31–Lin–PDGFRα+Sca1–) and PαS (CD45–CD31–Lin–PDGFRα+Sca1+) cells.  
d, Representative immunoblot analysis of EBF1 protein level in total cells extracts from 1x104 sorted cells (n=2 independent experiments). actin was 
used as a loading control. EBF1 band is marked with an arrow. e, t-SNE map showing clusters of cells with similar transcriptomes within CaR and PαS 
populations, derived by RaceID3 algorithm. Data represent 1777 single-sorted wild-type and knockout cells from 3 independent experiments (n=4 mice 
per genotype). f, t-SNE map showing distribution of CaR and PαS cells from Ebf1+/+Prx1Cre mice (black) and from Ebf1fl/flPrx1Cre mice (blue) within established 
clusters. g, Ma plot showing differential gene expression between Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre cells from scRNa-seq analysis. Upregulated genes are 
shown in red and downregulated genes are shown in blue. Source data.
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Extended Data Fig. 2 | See next page for caption.
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Extended Data Fig. 2 | Ebf1 deficiency alters MSC in vitro differentiation. Integrated analysis of the scRNa-seq dataset from CaR and PαS cells from 
Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice with data published by Tikhonova et al. and Baryawno et al. a, UMaP plot depicting cells collored by used technology 
CEL-Seq2 (blue) utilized by Derecka et al. study or 10x (red) utlized by Tikhonova et al. study. b, UMaP plot depicting cells collored by used technology 
CEL-Seq2 (blue) utilized by Derecka et al. study or 10x (red) utlized by Baryawno et al. study. c, Percentage of annexin V positive CaR and PαS cells in the 
BM. Data represent the mean ± s.e.m, for 3 independent experiments, n=13 Ebf1+/+Prx1Cre mice and n=12 Ebf1fl/flPrx1Cre mice. Percentage of CaR and PαS 
cells within each cell cycle phase. Data represent the mean ± s.e.m, for 3 independent experiments, n=11 (CaR) and n=14 (PαS) Ebf1+/+Prx1Cre mice and 
n=11 (CaR) and n=12 (PαS) Ebf1fl/flPrx1Cre mice (*P=0.02 for G0, *P=0.04 for G1, *P=0.01 for s/G2/M). d, histomorphometric analysis of tibiae from n=12 
Ebf1+/+Prx1Cre and n=12 Ebf1fl/flPrx1Cre mice showing bone volume as a percentage of tissue volume (BV/TV) in the trabecular area of the bone (*P=0.01) and 
osteoblast surface as a percentage of bone surface (Ob.S/BS) in the trabecular (*P=0.03) and endocortical area of the bone. e, Quantification of CFU-F 
colonies from sorted CaR and PaS cells. Data are presented as mean ± s.e.m for 3 independent experiments, n=9 for Ebf1+/+Prx1Cre and n=10 for Ebf fl/fl 
Prx1Cre mice (*p=0.03, ***p=0.0003). f, Representative images showing multilineage differetiation of CFU-F colonies from PαS cells from Ebf1+/+Prx1Cre 
and Ebf1fl/flPrx1Cre mice (n=3 independent experiments). adipocytes were stained with Oild Red O, osteoblasts with alizarin Red S and chondrocytes 
with Toluidine Blue. g, Relative mRNa expression levels of mesenchymal lineage-specific markers from PαS-derived CFU-F colonies sub-cloned into 
secondary cultures and subjected to adipogenic, osteogenic and chondrogenic in vitro differentiation. Data are represented as mean fold change ± s.e.m 
over Ebf1+/+Prx1Cre cells set as 1, for 3 independent experiments, n=26 clones from Ebf1+/+Prx1Cre mice and n=35 clones from Ebf1fl/flPrx1Cre mice (adipogenic 
differentiation); n=32 clones for each genotype (Osteogenic fifferentiation); n=38 clones from Ebf1+/+Prx1Cre mice and n=48 clones from Ebf1fl/flPrx1Cre mice 
(Chondrogenic differentiation). Statistical analysis in c, d, e, g was performed using two-tailed unpaired Student’s t-test.
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Extended Data Fig. 3 | See next page for caption.
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Extended Data Fig. 3 | Prx1Cre mediated deletion of Ebf1. a, Total BM cellularity. Data represent the mean ± s.e.m, n=22 Ebf1+/+Prx1Cre mice and n=20  
Ebf1fl/flPrx1Cre mice. b, Quantification of CFU colonies from the spleen and peripheral blood. Data represent the mean ± s.e.m, for 3 independent 
experiments, n=12 Ebf1+/+Prx1Cre mice and n=10 Ebf1fl/flPrx1Cre mice. SP-spleen, PB-peripheral blood. c, Frequency of neutrophils (CD11b+CD11c–Ly6G+), 
monocytes (CD11b+CD11c–Ly6Chi) and macrophages (MhC-II+CD11b+F4/80+) in the BM. Data represent the mean ± s.e.m, n=10 Ebf1+/+Prx1Cre mice 
and n=12 Ebf1fl/flPrx1Cre mice (*P=0.03, **P=0.001). d, absolute numbers of B cells (CD19+B220+) with n=14 mice per group, T cells (CD3+) with 
n=16 Ebf1+/+Prx1Cre mice and n=15 Ebf1fl/flPrx1Cre mice and erythroid cells (Ter119+) with n=15 Ebf1+/+Prx1Cre mice and n=14 Ebf1fl/flPrx1Cre mice, in the BM. 
e, Quantification of early B cell subsets: common lymphoid progenitors-CLP (Lin–Sca1loc-kitloIL-7Rα+CD135+) with n=10 mice per group, pro-B cells 
(B220+CD43+), pre-B cells (B220loCD43–) and rec-B cells (B220hiCD43–) with n=14 mice per group, in the BM. Statistical analysis in a-e was performed 
using two-tailed unpaired Student’s t-test.
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Extended Data Fig. 4 | See next page for caption.
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Extended Data Fig. 4 | LepRCre and NG2Cre-ERtM dependent deletion of Ebf1. a, Total BM cellularity. Data represent the mean ± s.e.m, n=22 Ebf1+/+LepRCre 
mice and n=20 Ebf1fl/flLepRCre mice. b, absolute numbers of MPP3 (CD135–CD48+CD150–LSK) and MPP4 (CD135+ CD150–LSK) in the BM. Data represent 
the mean ± s.e.m, n=17 Ebf1+/+LepRCre mice and n=20 Ebf1fl/flLepRCre mice (*P=0.02). c, Numbers of CLPs (Lin–Sca1loc-kitloIL-7Rα+CD135+) in the BM. 
Data represent the mean ± s.e.m, n=12 Ebf1+/+LepRCre mice and n=13 Ebf1fl/flLepRCre mice (*P=0.03). d, Frequency of neutrophils (CD11b+CD11c–Ly6G+) 
(*P=0.03), monocytes (CD11b+CD11c–Ly6Chi) and macrophages (MhC-II+CD11b+F4/80+) (*P=0.01) in the BM. Data represent the mean ± s.e.m, n=8 
mice per group. e, absolute numbers of T cells (CD3+) and erythroid cells (Ter119+) in the BM. Data represent the mean ± s.e.m, n=22 (T cells) and n=19 
(erythroid) Ebf1+/+LepRCre mice and n=19 Ebf1fl/flLepRCre mice. f, Numbers of B lineage cells (CD19+B220+) with n=13 mice per group, including pro-B cells 
(B220+CD43+), pre-B cells (B220loCD43–) and rec-B cells (B220hiCD43–) with n=12 mice per grop, in the BM of Ebf1fl/flLepRCre and Ebf1+/+LepRCre mice. Data 
represent the mean ± s.e.m (**p=0.03). g, Total BM cellularity. Data represent the mean ± s.e.m, n=16 Ebf1+/+ NG2Cre-ERTM mice and n=17 Ebf1fl/flNG2Cre-ERTM 
mice. h, absolute numbers of MPP3 (CD135–CD48+CD150–LSK) and MPP4 (CD135+ CD150–LSK) in the BM. Data represent the mean ± s.e.m, n=16 mice 
per group. I, Numbers of B cells (CD19+B220+), T cells (CD3+) and erythroid cells (Ter119+) in the BM of Ebf1fl/flNG2Cre-ERTM and Ebf1+/+NG2Cre-ERTM mice. Data 
represent the mean ± s.e.m, n=12 mice per group. Statistical analysis in a-i was performed using two-tailed unpaired Student’s t-test.
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Extended Data Fig. 5 | See next page for caption.
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Extended Data Fig. 5 | Chromatin accessibility in CaR and PαS cells from Ebf1+/+ and Ebf1–/– mice. a, Frequency and absolute number of hSCs in the 
spleens of Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice after G-CSF treatment. G-CSF was administered subcutaneously once a day for six consecutive days. 
Mice were analyzed on day 7 from the start of G-CSF treatment. Data represent the mean ± s.e.m, for 3 independent experiments, n=7 mice per group 
(*p=0.03, two-tailed unpaired Student’s t-test). b, Venn diagram showing the numbers of identified aTaC peaks in CaR and PαS cells from Ebf1+/+ and 
Ebf1–/– mice. c, Percentage of aTaC peaks in different genomic regions in CaR and PαS cells. d, Motifs identified in clusters presented in Fig.4g. e, Venn 
diagrams comparing differentially expressed genes with differential aTaC peaks containing EBF motif in CaR and PαS cells from Ebf1+/+ and Ebf1–/– mice. 
Upregulated genes are in red and downregulated genes are in green. all genes marked by black circle in WT only cluster (blue box) show loss of aTaC 
signal within EBF motif in Ebf1–/– (KO) cells. Genes marked by black circle in common cluster show loss of EBF1-specific footprint in Ebf1-/- cells. f, Digital 
genomic footprinting analysis showing average normalized Tn5 insertion profiles around EBF footprinted motifs in merged aTaC peaks. Insertions on the 
forward and reverse strands are indicated in red and blue, respectively.
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Extended Data Fig. 6. | transplantation of HSCs from Ebf1-deficient niche to wild-type recipients. a, Percent of chimerism in peripheral blood (PB) during 
the course of experiment. Percentage of CD45.2+ donor-derived cells in PB within myeloid cells (Mac1+) b, B cells (CD19+) c, and T cells (CD3+) d over 
time. Data represent the mean ± s.e.m with n=18 recipients of hSCs from Ebf1+/+Prx1Cre mice and n=18 recipients of hSCs from Ebf1fl/flPrx1Cre mice in the 
primary bone marrow transplantation and n=20 recipients of hSCs from Ebf1+/+Prx1Cre mice and n=29 recipients of hSCs from Ebf1fl/flPrx1Cre mice in the 
secondary bone marrow transplantation.
NatuRE IMMuNoLoGy | www.nature.com/natureimmunology
Articles NATuRE IMMuNoloGy
Extended Data Fig. 7 | See next page for caption.
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Extended Data Fig. 7 | Niche-dependent changes in HSCs chromatin accessibility and transcriptome. a, aTaC signal ±3 Kb around the center of the 
peak. b, Motifs identified in clusters with lost and gained accessibility in hSCs from Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice. c, heatmaps showing footprinted 
motif co-occurrence enrichment clustering. d, GSEa plot showing enrichments of myeloid cells differentiation signature in hSCs derived from wild-type 
niche. The Normalized Enrichment Score (NES) was computed using a Kolmogorov–Smirnov statistic. Significance was assessed using a two-tailed t-test 
comparing to a null distribution computed via 1000 gene-set permutations. Correction for multiple testing was performed using FDR adjustment, n=183. 
e, Representative tracks showing differential merged aTaC signal in hSCs from Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice correlated with genes differentially 
expressed between cluster 2 and 3 (Fig 6e). Region on chromosome 8 with Pcm1 and Asah1 serves as a control without differential aTaC signal. The scale 
in the y-axis represents RPKM.
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Extended Data Fig. 8 | See next page for caption.
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Extended Data Fig. 8 | Niche-dependent changes in HSCs composition. a, t-SNE maps highlighting normalized expression of Mki67 in sequenced hSCs. 
b, Representative tracks showing differential merged aTaC signal in hSCs from Ebf1+/+Prx1Cre and Ebf1fl/flPrx1Cre mice correlated with genes differentially 
expressed between cluster 2 and 3 (Fig. 7e). Region on chromosome 1 with Fbxo36 and Cab39 serves as a control without differential aTaC signal. The 
scale in the y-axis represents RPKM. c, t-SNE map showing clusters of cells with similar transcriptomes within LSK (Lin–Sca-1+c-kit+) populations, derived 
by RaceID3 algorithm. Data represent 2844 single-sorted wild-type and knockout cells from 2 independent experiments (n=5 mice for Ebf1+/+Prx1Cre 
group and n=6 mice for Ebf1fl/flPrx1Cre group). d, t-SNE map displaying clusters with statistically significant enrichment of wild-type cells (cluster 6) or Ebf1-
deficient cells (cluster 3 and 10) within LSK population. Data represent 2844 single-sorted wild-type and knockout cells from 2 independent experiments 
(n=5 mice for Ebf1+/+Prx1Cre group and n=6 mice for Ebf1fl/flPrx1Cre group). Fisher’s exact test was used for statistics (exact P values and cell numbers for 
each cluster are provided in Supplementary Table 5). e, t-SNE maps showing normalized expression of Mpo in sequenced LSKs. f, t-SNE maps showing 
normalized expression of Ctsg in sequenced LSKs. g, Ma plot showing differential gene expression between cluster 10 and cluster 11 from scRNa-seq 
analysis of LSKs. Genes upregulated in cluster 11 are shown in red and downregulated genes are shown in blue.
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any manipulations. State what population the sample is meant to represent when applicable. For studies involving existing datasets, 
describe the data and its source.
Sampling strategy Note the sampling procedure. Describe the statistical methods that were used to predetermine sample size OR if no sample-size 
calculation was performed, describe how sample sizes were chosen and provide a rationale for why these sample sizes are sufficient.
Data collection Describe the data collection procedure, including who recorded the data and how.
Timing and spatial scale Indicate the start and stop dates of data collection, noting the frequency and periodicity of sampling and providing a rationale for 
these choices. If there is a gap between collection periods, state the dates for each sample cohort. Specify the spatial scale from which 
the data are taken
Data exclusions If no data were excluded from the analyses, state so OR if data were excluded, describe the exclusions and the rationale behind them, 
indicating whether exclusion criteria were pre-established.
Reproducibility Describe the measures taken to verify the reproducibility of experimental findings. For each experiment, note whether any attempts to 
repeat the experiment failed OR state that all attempts to repeat the experiment were successful.
Randomization Describe how samples/organisms/participants were allocated into groups. If allocation was not random, describe how covariates were 
controlled. If this is not relevant to your study, explain why.
Blinding Describe the extent of blinding used during data acquisition and analysis. If blinding was not possible, describe why OR explain why 
blinding was not relevant to your study.
Did the study involve field work? Yes No
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Materials & experimental systems













Antibodies used Flow cytometry antibodies: 
BM lineage cocktail: CD3 (clone 145-2C11; cat # 100306 or 100304; BioLegend), CD11b (clone M1/70; cat # 101206 or 101204; 
BioLegend), Gr-1 (clone RB6-8C5; cat # 108406 or 108404; BioLegend), CD19 (clone 1D3/CD19; cat # 152404; clone 6D5; cat # 
115504; BioLegend), B220 (clone RA3-6B2; cat # 103206 or 103204; BioLegend), Ter119 (clone TER-119; cat # 116206 or 
116204; BioLegend) 
CD117 (clone 2B8; cat # 105828 or 105808; BioLegend) 
Sca-1 (clone D7; cat # 108112; BioLegend) 
CD135 (clone A2F10; cat # 135306; BioLegend) 
CD150 (clone TC15-12F12.2; cat # 115927 or 115936; BioLegend) 
CD48 (clone HM48-1; cat # 103422; BioLegend) 
CD45 (clone 30-F11; cat # 103108 or 103104; BioLegend) 
CD45.1 (clone A20; cat # 110708; BioLegend) 
CD45.1 (clone 104; cat # 109806 or 109830; BioLegend) 
CD31 (clone 390; cat # 102406 or 102404; BioLegend) 
CD140a (clone APA5; cat # 135906; BioLegend) 
CD51 (clone RMV-7; cat # 104106; BioLegend) 
CD51 (clone RMV-7; cat # 104106; BioLegend) 
CD19 (clone 6D5; cat # 115520; clone 1D3/CD19; cat # 152406; BioLegend) 
CD43 (clone S7; cat # 560663; BD) 
CD24 (clone M1/69; cat # 48-0242-82; eBioscience) 
CD249 (clone BP-1; cat # 553735; BD) 
CD11b (clone M1/70; cat # 101212 or 101236; BioLegend)  
CD11c (clone N418; cat # 12-0114-82; eBioscience) 
NK-1.1 (clone PK136; cat # 108724; BioLegend) 
Gr-1 (clone RB6-8C5; cat # 108408; BioLegend) 
Ly-6C (clone HK1.4; cat # 128015; BioLegend) 





Ly-6G (clone 1A8; cat # 127605; BioLegend) 
I-A/I-E (clone M5/114.15.2; cat # 107629; BioLegend) 
F4/80 (clone BM8; cat # 69-4801-80; eBioscience) 
CD127 (clone A7R34; cat # 135032; BioLegend) 
Ki67 (clone SolA15; cat # 25-5698-82 or 11-5698-82; eBioscience) 
 
Immunoblot antibodies: 
EBF1 (produecd in-house and referenced in Methods section) 
Actin (cat # A2066; Sigma-Aldrich)
Validation All antibodies are commercial clones that have been referenced in the literature. All antibodies used in the study were also 
titrated prior to experiments. 
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) MS-5 cells were kindly provided by Dr. E. Dzierzak (University of Edinburgh Medical School, UK).
Authentication Authentication was not performed.
Mycoplasma contamination Tested negative.
Commonly misidentified lines
(See ICLAC register)
Not used in the study.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals The following mouse strains were used in the study : 
Prx1-Cre (B6.Cg-Tg(Prrx1-cre)1Cjt/J; stock # 005584; The Jackson laboratory) 
LepR-Cre (B6.129(Cg)-Leprtm2(cre)Rck/J; stock # 008320; The Jackson laboratory) 
NG2-Cre-ERTM (B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J; stock # 008538; The Jackson laboratory) 
CD45.1 (B6.SJL-Ptprca Pepcb/BoyJ; stock # 002014; The Jackson laboratory) 
Ebf1+/- and Ebf1fl/fl mice were generated according to what has been previously described (Methods section). 
Unless indicated otherwise in the text, 8-14 week old male and female mice were used for experiments.
Wild animals Wild animals were not involved in the study.
Field-collected samples Field-collected samples were not used in the study.
Ethics oversight All animal procedures were performed according to protocols approved by the German authorities and Regierungspräsidium 
Freiburg.




The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Intact bones (femora and tibia) were chopped into small fragments and crushed in FACS buffer (PBS-2% FCS) using pestle and 
mortar. Bone marrow cells were collected and RBC lysis was performed. Next, the cells were washed with FACS buffer and 
stained for analysis. For sorting of HSPCs the cells were enriched by magnetic depletion. Briefly, the BM cells were labeled with a 
cocktail of biotinylated antibodies (CD3, CD19, B220, CD11b, Gr1 and Ter119) and then with streptavidin-conjugated magnetic 
nanobeads (BioLegend). For non-hematopoietic BM cell isolation, the bone chips were digested with 0.3% collagenase type II 
and 0.02% DNase I at 37°C for 45 min with gentle shaking. After enzymatic digestion, the cells were filtered, washed with FACS 
buffer, and stained accordingly.
Instrument BD FACSAria Fusion was used for fluorescence-activated cell sorting and BD LSRFortessa was used for flow cytometry.





Software Data were analyzed with FlowJo software (TreeStar).
Cell population abundance The average abundance of each analyzed cell population is indicated in the results.
Gating strategy LSKs (Lin-Sca1+c-kit+), HSCs (CD135-CD48-CD150+LSK), MMP3 (CD135-CD48+CD150-LSK), MPP4 (CD135+ CD150-LSK), CLPs (Lin-
Sca1loc-kitloIL-7Rα+CD135+), pro-B cells (B220+CD43+), pre-B cells (B220loCD43-), rec-B cells (B220hiCD43-), B cells (B220
+CD19+), T cells (CD3+), myeloid cells (Mac1+Gr1+), erythroid cells (Ter119+), neutrophils (CD11b+CD11c-Ly6G+), monocytes 
(CD11b+CD11c-Ly6Chi), macrophages (MHC-II+CD11b+F4/80+), CAR cells (CD45-CD31-Lin-PDGFRα+Sca1-), PαS cells (CD45-
CD31-Lin-PDGFRα+Sca1+), OB (CD45-CD31-Lin-CD51+ Sca1-), OP (CD45-CD31-Lin-CD51+ Sca1+) and EC (CD45-Lin-CD31+ Sca1+).
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
